We are thrilled to welcome Heather to the Avalyn team and to her new role as Board Chair,” said Lyn Baranowski, chief executive officer of Avalyn. “As we look ahead, we are excited to tap into Heather ...

Aileron Therapeutics' Phase 1b trial shows LTI-03 improved biomarkers and reduced SPD levels, indicating the potential to ...

Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, today reported financial results for the third quarter ...

The topline data showed ISM001-055 to have improved the forced vital capacity (FVC) of IPF patients studied 12 weeks after ...

Infectious and non-infectious respiratory diseases are regarded as accelerated-age conditions in which chronic inflammation, exacerbated/dysregulated immune responses, and immunological senescence ...

Mechanical engineers have developed a system of artificial cilia capable of monitoring mucus conditions in human airways to better detect infection, airway obstruction, or the severity of diseases ...

Xiaoguang Dong, assistant professor of mechanical engineering, is leading a team of researchers that has developed a system of artificial cilia capable of monitoring mucus conditions in human airways ...

Fibrosis, or scarring, plays a major role in many diseases and is often accompanied by inflammation. Pulmonary fibrosis refers to scarring in the lungs, which damages lung tissue, making it harder for ...

Xiaoguang Dong, assistant professor of mechanical engineering at Vanderbilt University, is leading a team of researchers that ...

Although Utahns do not smoke tobacco at the rate of Americans in most states, it doesn’t mean they are not vulnerable to lung ...

Maria L. Padilla, MD, Icahn School of Medicine at Mount Sinai, previews that experts will discuss critical management strategies for interstitial lung disease and idiopathic pulmonary fibrosis, ...